Cancer drug study halted early after just 5 patients
Knowledge-focused
Terminated
This study tested an experimental drug called IBI3004 in people with advanced solid tumors that could not be removed by surgery. The goal was to find the safest dose and check for side effects. However, the study was stopped early after only 5 people took part, so no clear conclu…
Phase: PHASE1, PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated Apr 29, 2026 04:29 UTC